Teva Pharmaceutical Industries Limited engages in the development, manufacture, and marketing of generic and human pharmaceuticals, active pharmaceutical ingredients (APIs), and animal health pharmaceutical products. It offers generic pharmaceutical products in various dosage forms, including tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company also provides specialty pharmaceutical products, such as respiratory, bio-generics, and biopharmaceutical products, as well as focuses on hospitals and institutional franchises. Teva Pharmaceutical was founded in 1901 and is headquartered in Petach Tikva, Israel.

Acquired Companies: Bentley Pharmaceuticals Inc., Cephalon Inc., IVAX Corp., Barr Pharmaceuticals Inc., Sicor Inc., Gensia Sicor Pharmaceuticals, Copley Pharmaceutical, Inc., RatioPharm GmbH, Taiyo Pharmaceutical Industry Co., Ltd., Teva-Kowa Pharma Co., Ltd., Teva Biopharmaceuticals USA, Dorom S.R.L., Teva Pharmachemie BV, Theramex SpA